Implications of the Neuroprotective Effects of Lithium for the Treatment of Bipolar and Neurodegenerative Disorders

Keyphrases

• Neurodegenerative Diseases 100%
• Lithium 100%
• Bipolar Disorder 100%
• Neuroprotective Effect 100%
• Illness 40%
• Lithium Treatment 40%
• Neurocognitive Function 40%
• Myo-inositol 20%
• Mitogen-activated Protein Kinase 20%
• Neurogenesis 20%
• Number of Signals 20%
• Cell Damage 20%
• Signal Transduction 20%
• Hippocampus 20%
• Protein Kinase 20%
• Neurotoxicity 20%
• Neuronal Damage 20%
• Neural Tissue 20%
• Drug Treatment 20%
• Glutamate Uptake 20%
• Bipolar Patients 20%
• Cell Loss 20%
• Neuroprotection 20%
• Protein Kinase B/Akt 20%
• Tissue Loss 20%
• Pharmacological Effects 20%
• Nase 20%
• Neuropsychiatric Disorders 20%
• Cortical Brain 20%
• Glutamatergic 20%
• Adult Neurogenesis 20%
• Limbic Brain 20%
• Mood-stabilizing Drugs 20%
• Glycogen Synthase 20%
• Kinase Protein 20%

Neuroscience

• Neurodegenerative Disorder 100%
• Neuroprotective Agent 100%
• Bipolar Disorder 66%
• Protein Kinase B 66%
• Neurogenesis 66%
• Mitogen-Activated Protein Kinase 33%
• Hippocampus 33%
• Glucocorticoid 33%
• Kinase 33%
• Protein Kinase C 33%
• Neuroprotection 33%
• Cell Loss 33%
• In Vitro 33%
• Glutamic Acid 33%
• Inositol 33%
• Excitotoxicity 33%
• Cell Damage 33%
• Glycogen Synthase 33%
• Mood Stabilizer 33%
• Signal Transduction 33%
• Drug Therapy 33%